Company newsSubmitted to enterprise news
Returns a list of news
Congratulating our invested project “Frontier Biotech” has been on the market successfully
Release date:2020-11-03

October 28, the company Frontier Biotech successfully landed on the Shanghai stock exchange, stock code 688221. price 20.5 per stock , company market value has exceeded 10 billion yuan.

We invest Frontier Biotech by Efung Capital in 2017 Oct.Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Their medicines typically address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. Aikening has proved to be a powerful tool in saving the lives of critically ill patients. Two additional drug candidates are currently undergoing multiple clinical trials in Phase II in the United States.

We will keep on eyes on medicine and health areas and explore more investment projects in the future.

Investment Department